Mallory Fox, a personal trainer based in Scottsdale, Arizona, said she's had many prospective clients ask about whether she works with people taking GLP-1s, to the point where she's considered developing an online program for those on the medications
Our latest strategy briefing has been written with these exact concerns in mind
For instance, in June 2024, Boehringer Ingelheim and Zealand Pharma reported notable efficacy of survodutide, their dual agonist targeting GLP-1 and glucagon receptors, in reducing liver fibrosis among patients with metabolic dysfunction-associated steatohepatitis (MASH)
GLP-1 medicines for weight loss are increasingly popular in the U.S., prompting employers to consider coverage for employees
10.3389/fcell.2020.586578 18 LaX.WangW.ZhangM.LiangL
Proper storage if liposomal